|Bid Price||-||Offer Price||-|
|Mid Price||GBX 112.40||Day Change||GBX +0.10 (0.09%)|
|Price Date||21 Sep 2017||Crown Rating|
|Shares Class||Inc.||Yield||3.90 %|
|Total Expense Ratio||0.00||Fund Size||482,500,000.00|
|Launch Date||07/02/2000||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.00||Sector||IMA UK Equity Income|
|Min Investment (£)||0.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00B99G2832||Min TopUp (£)||0.00|
The fund aims to provide a significantly higher level of income than that available on gilts by investing mainly in sterling and euro denominated sub-investment grade corporate bonds. The fund is actively managed by our investment team who may also invest in other bonds (such as investment grade corporate bonds and government bonds) to try to take advantage of the opportunities they have identified. Past performance is not a guide to future returns and future returns are not guaranteed. The price of assets and the income from them may go down as well as up and cannot be guaranteed; an investor may receive back less than their original investment. The fund will routinely use derivatives to reduce risk or cost, or to generate additional capital or income at low risk. Usage of derivatives is monitored to ensure that the fund is not exposed to excessive or unintended risks. The value of assets held within the fund may rise and fall as a result of exchange rate fluctuations.
Fraser joined Standard Life Investments in 2011 and is an Investment Director in the Credit team. He is the Lead Manager of the Ignis High Income Fund and also has responsibility for companies specialising in the Healthcare and Pharmaceutical sectors across the full bond spectrum. Previously, Fraser spent four years at Lehman Brothers as analyst and industry specialist for the Healthcare, Pharmaceuticals, and Chemicals sectors. He also worked for Deloitte, Edinburgh as an Assistant Manager in Assurance & Advisory Department. Fraser has 12 years’ experience in the industry, is a CFA Charterholder, a Chartered Accountant (CA) and holds a PhD in synthetic organic chemistry from Heriot-Watt University.